Bartonella quintana
Bartonella quintana is a gram-negative bacteria species and is the causative agent of trench fever, a disease that was first identified during World War I. This bacterium is a member of the genus Bartonella, which includes several other species that are also human pathogens.
History[edit]
Bartonella quintana was first identified during World War I, when it caused an outbreak of trench fever among soldiers. The bacterium was initially named Rickettsia quintana in honor of the American bacteriologist Stanford Quintan, but was later reclassified as Bartonella quintana.
Characteristics[edit]
Bartonella quintana is a gram-negative bacteria, meaning it does not retain the crystal violet stain used in the Gram stain procedure. It is a facultative intracellular parasite, which means it can live within or outside host cells. The bacterium is rod-shaped and is typically 1.5-2.0 micrometers in length.
Pathogenesis and Clinical Features[edit]
Bartonella quintana is transmitted to humans through the bite of an infected human body louse. Once in the human body, the bacterium can infect endothelial cells and red blood cells, leading to the symptoms of trench fever. These symptoms typically include fever, headache, and muscle pain, and can last for several weeks.
In addition to trench fever, Bartonella quintana can also cause bacillary angiomatosis, a disease characterized by the formation of tumor-like masses in the skin and internal organs, and endocarditis, an inflammation of the inner layer of the heart.
Diagnosis and Treatment[edit]
Diagnosis of Bartonella quintana infection is typically made through blood culture or serology, which involves testing for the presence of antibodies against the bacterium in the patient's blood. Treatment usually involves antibiotics, such as doxycycline or erythromycin.
See Also[edit]
Bartonella_quintana[edit]
-
Bacteria on Warthin–Starry stain
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

